SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Company · XNAS · US · USD
Market price
$41.19
−$0.606 (-1.45%) · 3 months
| Date and time | Price |
|---|---|
| Jun 25, 2026 | $41.80 |
| Jun 26, 2026 | $42.95 |
| Jun 29, 2026 | $43.43 |
| Jun 30, 2026 | $42.66 |
| Jul 1, 2026 | $41.63 |
| Jul 2, 2026 | $43.16 |
| Jul 6, 2026 | $42.61 |
| Jul 7, 2026 | $42.98 |
| Jul 8, 2026 | $42.78 |
| Jul 9, 2026 | $43.90 |
| Jul 10, 2026 | $43.50 |
| Jul 13, 2026 | $44.00 |
| Jul 14, 2026 | $43.18 |
| Jul 15, 2026 | $43.68 |
| Jul 16, 2026 | $44.21 |
| Jul 17, 2026 | $44.66 |
| Jul 20, 2026 | $43.98 |
| Jul 21, 2026 | $43.75 |
| Jul 22, 2026 | $43.79 |
| Jul 23, 2026 | $43.36 |
| Jul 24, 2026 | $43.35 |
| Jul 27, 2026 | $44.00 |
| Jul 28, 2026 | $45.54 |
| Jul 29, 2026 | $44.85 |
| Jul 30, 2026 | $42.89 |
| Jul 31, 2026 | $43.08 |
| Aug 3, 2026 | $42.95 |
| Aug 4, 2026 | $42.68 |
| Aug 5, 2026 | $42.78 |
| Aug 6, 2026 | $42.89 |
| Aug 7, 2026 | $43.46 |
| Aug 10, 2026 | $43.48 |
| Aug 11, 2026 | $43.56 |
| Aug 12, 2026 | $43.71 |
| Aug 13, 2026 | $43.78 |
| Aug 14, 2026 | $43.72 |
| Aug 17, 2026 | $44.41 |
| Aug 18, 2026 | $44.97 |
| Aug 19, 2026 | $45.83 |
| Aug 20, 2026 | $45.15 |
| Aug 21, 2026 | $45.85 |
| Aug 24, 2026 | $45.69 |
| Aug 25, 2026 | $46.02 |
| Aug 26, 2026 | $45.42 |
| Aug 27, 2026 | $44.84 |
| Aug 28, 2026 | $44.82 |
| Aug 31, 2026 | $44.36 |
| Sep 1, 2026 | $44.37 |
| Sep 2, 2026 | $44.47 |
| Sep 3, 2026 | $44.33 |
| Sep 4, 2026 | $44.24 |
| Sep 8, 2026 | $43.16 |
| Sep 9, 2026 | $42.85 |
| Sep 10, 2026 | $42.72 |
| Sep 11, 2026 | $42.77 |
| Sep 14, 2026 | $43.33 |
| Sep 15, 2026 | $42.40 |
| Sep 16, 2026 | $42.59 |
| Sep 17, 2026 | $43.14 |
| Sep 18, 2026 | $42.48 |
| Sep 21, 2026 | $42.50 |
| Sep 22, 2026 | $42.51 |
| Sep 23, 2026 | $41.66 |
| Sep 24, 2026 | $41.19 |
- Period change
- -1.45%
- Period low
- $41.19
- Period high
- $46.02
- Observations
- 64
- Updated
- Sep 24, 2026, 8:00 PM
About Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNAS
- Operating market
- XNAS
- Country
- US
- Currency
- USD
- Market capitalization
- $101,835,838,225.00
- Employees
- 74.8K